PLENARY LECTURE: Metabolic tumor suppressors and disease progression
Celeste Simon, PhD
  M. Celeste Simon, Ph.D. is the Scientific Director of the Abramson Family Cancer Research Institute of the Perelman School of Medicine at the University of Pennsylvania. She received her bachelor's degree from Miami University and completed a Ph.D. in biochemistry at Rockefeller University in 1985. She conducted postdoctoral research with Joseph Nevins at Rockefeller and then Stuart Orkin at Harvard Medical School. Dr. Simon became an Assistant Professor of Medicine/Molecular Genetics and Cell Biology at the University of Chicago in 1992. In its first National Competition, she was named an Assistant Investigator of the Howard Hughes Medical Institute in 1994, remaining an HHMI investigator for twenty years, until August, 2014.
  In 1999, Dr. Simon moved to the University of Pennsylvania School of Medicine and was one of the founding laboratories of the newly formed Abramson Family Cancer Research Institute (AFCRI) there. She was promoted to Associate Professor of Cell and Developmental biology in 1999, and full Professor in 2006. In 2007, she became the Scientific Director of the AFCRI. Dr. Simon's research is focused on how cells sense and respond to changes in the availability of molecular oxygen and nutrients. This affects normal development, physiology, and numerous diseases, such as the growth of solid tumors. The Simon Laboratory is studying how O2 sensing impacts tumor angiogenesis, inflammation, metabolism, metastasis, and overall disease progression. She is studying both animal models and cancer patient samples with the ultimate goal of developing novel strategies to treat tumors such as pancreatic cancer, soft tissue sarcoma, and colorectal cancer. Dr. Simon currently directs a laboratory of 20 individuals, including graduate students, postdoctoral fellows, clinical fellows, and research technicians. The AFCRI employs 400 researchers working in roughly 30 independent laboratories. Dr. Simon has received numerous awards recognizing her research, such as the Fouad Bashour Award for Distinguished Physiologists, Stanley N. Cohen Award for Biomedical Research, and Elliot Osserman Award from the Israel Cancer Research Fund. In 2014, she was elected to the American Academy of Arts and Sciences, as well as the Board of Directors for the American Association for Cancer Research.

SYMPOSIUM 1- History Committee: Complex DNA damage

Dudley Goodhead, PhD
Medical Research Council, UK
John Ward, PhD
University of California- San Diego
Peter O'Neill, PhD
Oxford Institute of Radiation Oncology
Susan Wallace, PhD, MS
University of Vermont

SYMPOSIUM 2- CNS effects on radiation

Richard Britten, PhD
Eastern Virginia Medical
Sandeep Burma, PhD
UT Southwestern Medical Center
Munjal Acharya, PhD
University of California, Irvine
Kristopher Sarosiek, PhD
Harvard School of Public Health
Susanna Rosi, PhD
University of California - San Francisco
SYMPOSIUM 3- Genomics of tumor response to radiation therapy
Max Diehn, MD, PhD
Stanford University
Nadeem Riaz, MD, MSc
Memorial Sloan Kettering Cancer Center
Mohamed Abazeed, MD, PhD
Cleveland Clinic
Scott Welford, PhD
University of Miami

Mark Chen
Duke University Medical Center

SYMPOSIUM 4- Radionuclides for imaging, therapy, and dosimetry
Rebecca Abergel, PhD
Lawrence Berkeley Laboratory
Jamey Wiechert, PhD
University of Wisconsin-Madison
Melissa Fath, PhD
University of Iowa

Jean-Pierre Pouget, PhD
SYMPOSIUM 5- Tumor microenvironment: SBRT tumor control

Marka Crittenden, MD, PhD
Providence Portland Medical Center
Stephen Brown, PhD
Henry Ford Health System
 Ehab Sarsour, PhD
Kansas City University of Medicine
 Yvonne Mowery, PhD
Duke University Medical Center
Rob Griffin, PhD
University of Arkansas for Medical Sciences
SYMPOSIUM 6- Canine translational radiation research (Co-sponsor: V Foundation)
Susan LaRue, DVM, PhD
Colorado State University
Michael Nolan, DVM, PhD
NC State University
Rebecca Tierce
 Colorado State University
 Ashlyn Rickard
Duke University Medical Center
 P. Jack Hoopes, DVM, PhD
Dartmouth Medical School
Charles Maitz, PhD
University of Missouri
SYMPOSIUM 7- DNA repair, immunity and inflammation

Samuel Bakhoum, MD, PhD
Memorial Sloan Kettering Cancer Center
Thomas Helleday, PhD
Karolinska Institutet
Andrew Lee
Duke University Medical Center

France Carrier, PhD
University of Maryland School of Medicine
Richard Frock, PhD
Stanford University
SYMPOSIUM 8- A million persons, a million dreams, a 25 year reality (Co-sponsor: NCRP)

Lawrence Dauer, PhD
Memorial Sloan Kettering Cancer Center
Dale Preston, PhD
Hirosoft International

Emily Caffrey, PhD
Radian Scientific, LLC

Sergei Tomachev, PhD
Washington State University
Ashley Golden, PhD
Oak Ridge Associated Universities
John Boice, Jr, PhD
Vanderbilt University School of Medicine

SYMPOSIUM 9- Radiation protectors and sensitizers

James Mitchell, PhD
NCI Center for Cancer Research
Tatjana Paunesku, PhD
Northwestern University
Minsi Zhang, PhD
Memorial Sloan Kettering Cancer Center

Sudip Banerjee, PhD
UAMS - College of Pharmacy

Sarwat Naz, PhD

SYMPOSIUM 10- Applied physics in translational radiobiology and medicine

Michela Marafini, PhD, MS
Centro Fermi-INFN Roma1
Wolfgang Tomé, PhD
Albert Einstein School of Medicine
Christian Graeff, PhD
Michelle Lis, PhD
GSI Helmholtz Centre for Heavy Ion Research

Duo Ma, PhD
UT MD Anderson Cancer Center

Léon Sanche, PhD
In 1971, Léon Sanche obtained a PhD from Yale in Engineering and Applied Sciences. Afterwards, he became associate professor at the University of Sherbrooke, Canada. His general career goal has been and still is to achieve a global comprehension of the basic mechanisms of radiation damage in biological systems and to apply this knowledge to enhance the therapeutic efficiency of radiation. To work efficiently toward this objective, he formed in 1982 a group of the Medical Research Council of Canada. His own research has been largely focused on the action of low-energy secondary electrons generated by ionizing radiation in condensed biomolecules, Dr. Sanche has published 443 refereed papers, 29 book chapters and trained about 50 students and postdoctoral fellows. He obtained the Distinguished Scientist Award from the Medical Research Council of Canada and more recently the Marie Curie Award for incoming senior scientists from the European Commission. In 2008, he was elected member of the Academy of Sciences of the Royal Society of Canada.


Xun Jia, PhD
UT Southwestern Medical Center
Chang W Song, PhD
University of Minnesota
Kristin Fabre, PhD, MS
Baylor College of Medicine
Tannishtha Reya, PhD
University of California San Diego
Randall Hyer, MD, PhD
National Council on Radiation Protection & Measurements
Charles Gersbach, PhD
Dr. Charles A. Gersbach is the Rooney Family Associate Professor at Duke University in the Departments of Biomedical Engineering and Surgery, an Investigator in the Duke Center for Genomic and Computational Biology, Director of the Duke Center for Biomolecular and Tissue Engineering, and Director of the Duke Center for Advanced Genomic Technologies. His research interests are in genome and epigenome editing, gene therapy, regenerative medicine, biomolecular and cellular engineering, synthetic biology, and genomics. Dr. Gersbach’s work has been recognized through awards including the NIH Director’s New Innovator Award, the NSF CAREER Award, the Outstanding New Investigator Award from the American Society of Gene and Cell Therapy, the Allen Distinguished Investigator award, and induction as a Fellow of the American Institute for Medical and Biological Engineering.

SYMPOSIUM 11- Radiomics and artificial intelligence in radiation therapy

Andrew Hope, MD
University of Toronto
Jing Wang, PhD
UT Southwestern Medical Center

Tien Tang, PhD
Baylor College of Medicine

Munira Kadhim, PhD 
Oxford Brookes University

SYMPOSIUM 12- Genome Editing (Joint session: AACR)
Kimberly Cooper, PhD
University of California- San Diego

Rhonda Bassel-Duby, PhD
UT Southwestern Medical Center
Neil Pfister, MD, PhD
Emory University
Jelena Popovic, PhD
Northwestern University

SYMPOSIUM 13- Normal tissue injury from radiation
Jenny Ting, PhD
University of North Carolina
School of Medicine
Nadia Haddy, PhD
Institut Gustave Roussy
Imene Mansouri, PhD
Gustave Roussy
Eun Joo Chung
Rachel Andrews, DVM PhD
Wake Forest University
Tyler Beach, PhD
SRI International 
SYMPOSIUM 14- Medical countermeasures against radiation
Karla Thrall, PhD
Vidya Kumar, PhD
Armed Forces Radiobiology
Research Institute
 Heather Himburg, PhD
UCLA Medical Center
Mang Xiao, MD
 Kelvin Li, MS
University of Pittsburgh Medical Center
SYMPOSIUM 15- Track structure and fast chemistry
Mehran Mostafavi, PhD
Université Paris-Sud
Emanuele Scifoni, PhD
Trento Institute for Fundamentals Physics Applications
Reza Taleei, PhD
University of Virginia
Nicholas Henthorn, MS
University of Manchester, Paterson Institute

Jan Schuemann, PhD
Massachusetts General Hospital

SYMPOSIUM 16- Space: We Are Going! (Co-sponsor: NASA)

Marco Durante, PhD
GSI Helmholtz Center
Jeff Willey, PhD, MS
Wake Forest School of Medicine
Vipan Parihar, PhD
University of California Irvine
Paul Wilson,  PhD
UC Davis Comprehensive Cancer Center
Jared Luxton, MS
Colorado State University
 Afshin Beheshti, PhD
NASA Ames Research Center

SYMPOSIUM 17- Biodosimetry for assessing radiation injury

Naduparambil Jacob, PhD
The Ohio State University
Evagelia Laiakis, PhD
Georgetown University
Evan Pannkuk, PhD
Georgetown University
Claude Rogers, PhD
Brian Ponniya
Columbia University
 Eloise Pariset, PhD
NASA Ames Research Center

SYMPOSIUM 18- Radiation chemistry of DNA

Ilko Bald, PhD
University of Potsdam
Michael Sevilla, PhD
Oakland University
Marc Greenberg, PhD
Johns Hopkins University
Amitava Adhikary, PhD
Oakland University

Vincent Lemelin
Université de Sherbrooke

SYMPOSIUM 19- DNA repair pathway choices

Weixing Zhao
UT Health San Antonio

 John Murnane, PhD
University of California, San Francisco
David Yu, MD, PhD
Emory University 
Thomas Genetta, PhD
University of Virginia Medical Center

 Claudia Wiese, PhD
Colorado State University

SYMPOSIUM 20- The beginning of the atomic age - risky business

Steve Simon, PhD
National Cancer Institute
Susan Bailey, PhD
Colorado State University
Koji Ono, PhD
Tokyo Health University
John Boice Jr, ScD
Vanderbilt University Medical Center

Michael Cornforth, PhD
University of Texas Medical Branch

Jason Bougere
US Department of Justice
Jeffrey Kotsch, MS
US Department of Labor- Medical & Health Sciences Unit


Karl Butterworth, PhD
Advanced technologies driving new biologies: exploiting physical and biological duality for optimised radiotherapy

Dr Butterworth is a Radiation Biologist with expertise in non-targeted effects and preclinical radiotherapy. He received his BSc in Biochemistry from the University of St Andrews, before undertaking a PhD at Ulster University which was followed by post-doctoral research focussing on metal nanoparticle radiosensitizers. In 2007, he joined Kevin Prise’s group and continued to work on metal nanoparticles whilst developing interests in radiation induced signalling and spatially fractionated radiotherapy. He has been a visiting scientist at Massachusetts General Hospital and the Italian National Agency for New Technologies, Energy and Sustainable Economic Development (ENEA), and is also a past Chair of the RRS Scholars-in-Training (SIT) Committee.

In 2015, he was appointed as Assistant Professor in Translational Radiation Biology at Queen’s University Belfast, where his lab now focuses on exploiting opportunities for biological optimisation in radiotherapy using combination treatments and understanding the basis of normal tissue injury. Central to his programme is the application of mouse models with small animal image guided radiotherapy, closely linking with preclinical imaging and functional tissue assessment.


SUNRISE SESSION (Co-sponsors: Columbia University, Center for Radiological Research and Rutgers Robert Wood Johnson Medical School) -
Methods in epidemiology

Eric J. Grant, PhD
Radiation Effects Research Foundation


Shan Zha, MD, PhD
Columbia University
John Zimbrick, PhD
Colorado State University
Marie Catherine Vozenin, PhD
Philippe Lambin, PhD
Maastricht University
Carmel Mothersill, PhD
McMaster University
PLENARY LECTURE: Evolving landscape of immunotherapy mechanisms and biomarkers
Timothy Chan, MD, PhD
  Dr. Chan is Vice Chair of the Department of Radiation Oncology and Director of the Division of Translational Oncology. He is a board-certified radiation oncologist with a special interest in treating patients with brain tumors. He specializes in the use of stereotactic radiosurgery, intensity-modulated radiation therapy (IMRT), and conformal radiation therapy to treat both benign and malignant brain tumors precisely and effectively, while minimizing the effects of treatment on nearby healthy tissue. Among the diseases he treats are acoustic neuroma, meningioma, glioblastoma, anaplastic astrocytoma, low-grade glioma, oligodendroglioma, pituitary adenoma, and ependymoma.
  Dr. Chan is a member of Memorial Sloan Kettering’s central nervous system disease management team, and works closely with neurosurgeons and neuro-oncologists to provide optimal care for their patients. He is also a member of the Brain Tumor Center.
  In addition to caring for patients, he is the principal investigator of a cancer genetics laboratory in the Human Oncology and Pathogenesis Program, where he and his colleagues are exploring the genetic changes that lead to cancer. They are dedicated to using their findings on the cancer genome to develop better diagnostic and treatment approaches that will improve the care of people with cancer.

SYMPOSIUM 21- Preclinical studies and clinical trials of radiosensitizers (Joint session: ASTRO)

Anthony Chalmers, PhD
University of Glasgow
Joseph Caster, MD, PhD
University of Iowa
Andrew Baschnagel, MD
University of Wisconsin - Madison

Linlin Yang, MD
The Ohio State University
 Ioannis Verginadis, PhD
University of Pennsylvania
SYMPOSIUM 22- Hypoxia and redox

Marianne Koritzinsky, PhD
University Health Network
Rebecca Oberley-Deegan, PhD
University of Nebraska Medical Center
Alexander Augustyn, MD, PhD
MD Anderson Cancer Center
Cullen Taniguchi, MD, PhD 
MD Anderson Cancer Center
 Kelly Hubert, BS
University of Iowa
SYMPOSIUM 23- HPV associated cancers and radiation response

Randy Kimple, MD, PhD
University of Wisconsin School of Public Health & Medicine
Julie Schwarz, MD, PhD
Washington University School of Medicine
Heath Skinner, MD, PhD
UPMC Hillman Cancer Center
Fiona Ruiz, BS
Washington University School of Medicine
Pippa Cosper, MD, PhD
Washington University School of Medicine

SYMPOSIUM 24- Harnessing DNA repair for cancer treatment

Patrick Sung, DPhil
Katharina Schlacher, PhD
MD Anderson Cancer Center
Zachary Nagel
Harvard T.H. Chan School of Public Health

Michael Goldstein,MD, PhD
Washington University in St. Louis School of Medicine
Allison DuRoss, BSE
Oregon State University

SYMPOSIUM 25- Pre-clinical mechanisms of immunotherapy and RT

Christopher Bakkenist, PhD
University of Pittsburgh Medical Center
Steven Lin, MD, PhD
MD Anderson Cancer Center
Amy Wisdom, BS
Duke University School of Medicine
Ravi Patel, PhD
University of Wisconsin - Madison
Lauren Zebertavage, BS
Oregon Health and Science University



Eleanor Blakely, PhD
Lawrence Berkeley National Laboratory
Lawrence Heilbronn, PhD, MS
University of Tennessee
Thomas Borak
Colorado State University 
Jeremy Stark, PhD
City of Hope
Ann Klopp, MD
MD Anderson Cancer Center
Lydia Zablotska, MD, MPA, PhD
University of California San Francisco
DR JACK LITTLE PLENARY LECTURE: Function and structure of human genetic variants of DNA repair genes
Joann Sweasy, PhD
Joann Sweasy, PhD is an expert in genetics, cell biology, mutagenesis and biochemistry of DNA repair and cancer. She has been funded continuously by the NIH since 1994. A major focus of her laboratory is to understand how single nucleotide polymorphisms in DNA repair genes, including genes that function in homology directed repair (HDR), nonhomologous end-joining (NHEJ) and base excision repair (BER) in the germline and somatic tissues impact cancer risk and treatment. The lab has recently found that RAD51, DNA glycosylase, and POLB germline and somatic tumor variants exhibit functional phenotypes that lead to cellular transformation, genomic instability, and sensitivity or resistance to chemotherapies and ionizing radiation. It has also developed methods to monitor DNA damage in tissue including the presence of single and double strand breaks that lead to PARP activation and trapping. In addition to this, Dr. Sweasy has focused on determining the roles of DNA repair in a vertebrate organism and has concentrated her studies on mouse models of DNA repair variants. Using these models, she has revealed critical roles for DNA repair in preventing the autoimmune disease of lupus. As Associate Director for Basic Research at the Yale Comprehensive Cancer Center, she oversees several pilot and internal grant competitions, is the Prinicipal Investigator of the American Cancer Society Institutional Research Grant, and is currently leading the development of a Translational Research Core which is designed to link patient health records to biospecimens, genomics data, and a living tumor registry.

SYMPOSIUM 26- Radiation-induced cancers

Chang-Lung Lee, PhD
Duke University School of Medicine
Jean Nakamura, MD
University of California- San Francisco
Harry Cullings, PhD
Radiation Effects Research Foundation

Jake Pirkkanen, BS, BA
Northern Ontario School of Medicine

Lin Ma, PhD
University of California, San Francisco
SYMPOSIUM 27- FLASH and other high intensity radiation therapies (Co-sponsor: RSS)

Billy Loo, MD, PhD
Stanford University School of Medicine
Pierre Montay-Gruel, PhD
L'Université de Lausanne
 Constantinos Koumenis 
University of Pennsylvani
Cristian Fernandez-Palomo, PhD
University of Bern

Pankaj Chaudhary, PhD
Centre of Cancer Research and Cell Biology Queen's University

Jinghui Wang
Stanford University School of Medicine
SYMPOSIUM 28- Radiation cytogenetics and cytogenomics


George Iliakis, PhD, MS
University Hospital Essen
Ralf Kittler, PhD
UT Southwestern Medical Center
Rhona Anderson, PhD
Brunel University
Megumi Hada, PhD
Prairie View A&M University
Sharif Mortoga
University of Duisburg-Essen

SYMPOSIUM 29- Radiation dosimetry: in patients and phantoms
George Xu, PhD
Rensselaer Polytechnic Institute
Mark Oldham, PhD
Duke Cancer Institute    
Michelle Howard
Mayo Clinic

 Guy Garty, PhD
Columbia University

SYMPOSIUM 30- Imaging and circulating biomarkers of radiation response
Everett Moding, MD, PhD
Stanford University School of Medicine
Anne Marie O'Broin-Lennon,
Johns Hopkins Medical Institute
 Sina Dadgar, MS
University of Arkansas
Steven Zhang 
University of Florida
Nadja Pejovic, BS
Washington University School of Medicine

PAINTER DEBATE- SBRT vs Hadron Therapy
FOR (for SBRT) AGAINST (for Hadron Therapy)

Puneeth Iyengar, MD, PhD
UT Southwestern Medical Center 
Marco Durante, PhD
GSI Helmholtz Center


Bryan Allen, MD, PhD
Targeting redox biochemistry to protect against radiation and chemotherapy induced normal tissue injury

Bryan G. Allen MD, PhD, is an associate professor and physician scientist in the Department of Radiation Oncology at the University of Iowa Hospitals and Clinics. He is co-program leader for the Experimental Therapeutics program in the NCI designated Holden Comprehensive Cancer Center. Dr. Allen is a redox biochemist with expertise in manipulating metabolic oxidative stress to enhance radiation and chemotherapy effectiveness and reduce cancer therapy associated normal tissue toxicities. He is also a practicing radiation oncologist who develops and leads clinical trials translating research discoveries from the bench to the bedside and taking clinical observations back to the bench for analysis. Dr. Allen is currently funded for investigations on the role of redox active iron in pharmacological ascorbate’s selective toxicity to cancer cells and the metabolic mechanisms behind why tissues from elderly patients are more susceptible to radiation and chemotherapy induced normal tissue toxicity.

PRESIDENTIAL SYMPOSIUM - Gender and the Genome (Joint session: Rad Women in Science)

Marjan Boerma, PhD
University of Arkansas

Isabel Jackson, PhD
University of Maryland
Karen Krukowski, PhD
University of California- San Francisco
Brinda Rana, PhD
UC San Diego School of Medicine

380 Ice Center Lane, Suite C | Bozeman, MT 59718 | 1.877.216.1919
Member & Exhibitor Services: Audrey Rinehart |
1.877.216.1919  |  audrey@radres.org